Elevated hepatocyte growth factor level correlates with poor outcome in early-stage and late-stage adenocarcinoma of the lung

Chest. 2004 May;125(5 Suppl):116S-9S. doi: 10.1378/chest.125.5_suppl.116s.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / chemistry*
  • Adenocarcinoma / mortality
  • Adenocarcinoma / pathology
  • Hepatocyte Growth Factor / analysis*
  • Humans
  • Lung Neoplasms / chemistry*
  • Lung Neoplasms / mortality
  • Lung Neoplasms / pathology
  • Multivariate Analysis
  • Neoplasm Staging
  • Prognosis
  • Survival Analysis
  • Survival Rate

Substances

  • Hepatocyte Growth Factor